Related Experiment Video

Updated: Jul 24, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Reading and assessing reports of treatment studies in oncology

R Simon1

  • 1Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

The Surgical Clinics of North America
|June 3, 2000
PubMed

Insights

Randomized clinical trials are crucial for determining effective cancer treatments. Supporting these trials ensures progress against cancer for current and future patients.

Area of Science:

  • Oncology
  • Clinical Research
  • Medical Science

Background:

  • Advances in tumor biology, immunology, genomics, and technology offer hope for improved cancer patient outcomes.
  • The efficacy of novel cancer therapies is not always clear, potentially slowing progress.
  • Definitive answers regarding treatment effectiveness are essential for advancing cancer care.

Purpose of the Study:

  • To emphasize the critical role of randomized clinical trials in cancer research.
  • To advocate for the support and participation of healthcare professionals in clinical trials.
  • To highlight the importance of evidence-based medicine in oncology.

Main Methods:

  • The abstract discusses the necessity of carefully designed, randomized clinical trials.
  • It implies a need for infrastructure, commitment, cooperation, time, and financial resources for conducting these trials.
  • The focus is on the methodology of generating reliable evidence for treatment efficacy.

Main Results:

  • Randomized clinical trials provide clear answers on treatment effectiveness, distinguishing between successful and unsuccessful interventions.
  • These trials are an invaluable contribution to medical knowledge and patient care.
  • The results underscore the definitive nature of evidence generated through rigorous clinical trials.

Conclusions:

  • Randomized clinical trials are indispensable for validating cancer treatments and guiding clinical decision-making.
  • Surgeons and oncologists should actively support, participate in, and demand high-quality clinical trials.
  • Investing in and conducting these trials is vital for the future of cancer treatment and patient outcomes.

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...